Cargando…

Immunotherapeutic Value of Transcription Factor 19 (TCF19) Associated with Renal Clear Cell Carcinoma: A Comprehensive Analysis of 33 Human Cancer Cases

BACKGROUND: We aimed to study the relationship between transcription factor 19 (TCF19) and cancer immunotherapy in the 33 types of human cancers. METHODS: The Cancer Genome Atlas database was analyzed to obtain the gene expression data and clinical characteristics for the cases of 33 types of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Xiaobao, Hou, Jian, Wen, Xiangyang, Dong, Runan, Lu, Zhenquan, Jiang, Yi, Wu, Guoqing, Yuan, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470357/ https://www.ncbi.nlm.nih.gov/pubmed/36111242 http://dx.doi.org/10.1155/2022/1488165

Ejemplares similares

Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer
por: Hou, Jian, et al.
Publicado: (2022)

A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor
por: Mo, Zhuomao, et al.
Publicado: (2021)

Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma
por: Tang, Haibin, et al.
Publicado: (2022)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2
por: Xu, Shengshan, et al.
Publicado: (2023)

The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021)

Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma
por: Xu, Jin, et al.
Publicado: (2022)

An Integrated Pan-Cancer Analysis of 33 Human Cancers Reveals the Potential Clinical Implications and Immunotherapeutic Value of C-X-C Motif Chemokine Ligand 13
por: Zhang, Huanyu, et al.
Publicado: (2022)

Immunology and Immunotherapeutic Approaches for Advanced Renal Cell Carcinoma: A Comprehensive Review
por: Hah, Yoon-Soo, et al.
Publicado: (2021)

COVID-19: immunopathogenesis and Immunotherapeutics
por: Yang, Li, et al.
Publicado: (2020)

Immunomodulation and immunotherapeutics of COVID-19
por: Garg, Sourbh Suren, et al.
Publicado: (2021)

Comprehensive exploration of the expression and prognostic value of AQPs in clear cell renal cell carcinoma
por: Wang, Huanrui, et al.
Publicado: (2022)

Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm
por: Chen, Siteng, et al.
Publicado: (2022)

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney
por: Gooskens, Saskia L., et al.
Publicado: (2015)

Integrated analysis to identify the prognostic and immunotherapeutic roles of coagulation-associated gene signature in clear cell renal cell carcinoma
por: Yin, Guicao, et al.
Publicado: (2023)

Tumor-infiltrating TNFRSF9(+) CD8(+) T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response
por: Li, Yaohui, et al.
Publicado: (2020)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1
por: Dong, Shiqiang, et al.
Publicado: (2022)

Immunotherapeutic approaches to curtail COVID-19
por: Owji, Hajar, et al.
Publicado: (2020)

A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma
por: Hou, Jian, et al.
Publicado: (2022)

Prognostic value of immune-related genes in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
por: Şenbabaoğlu, Yasin, et al.
Publicado: (2016)

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma
por: Zhu, Yuanyuan, et al.
Publicado: (2021)

Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment
por: Seledtsov, Victor Ivanovich, et al.
Publicado: (2023)

Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma
por: Sepe, Pierangela, et al.
Publicado: (2020)

COVID-19: benefits and risks of passive immunotherapeutics
por: Gupta, Ankur, et al.
Publicado: (2020)

Antibody-Based Immunotherapeutic Strategies for COVID-19
por: Hussen, Jamal, et al.
Publicado: (2020)

Immunotherapeutics for Covid-19 and post vaccination surveillance
por: Sampath Kumar, N. S., et al.
Publicado: (2020)

Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
por: Mohamed Khosroshahi, Leila, et al.
Publicado: (2021)

Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
por: Şenbabaoğlu, Yasin, et al.
Publicado: (2017)

TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro
por: Xu, Yingkun, et al.
Publicado: (2020)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

Comprehensive Analysis of ATP6V1s Family Members in Renal Clear Cell Carcinoma With Prognostic Values
por: Li, Xiaojuan, et al.
Publicado: (2020)

Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma
por: Lin, Shitong, et al.
Publicado: (2020)

Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis
por: Zhao, Zhixun, et al.
Publicado: (2022)

Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis
por: Hou, Lin, et al.
Publicado: (2023)

Comprehensive Exploration of Novel Chimeric Transcripts in Clear Cell Renal Cell Carcinomas Using Whole Transcriptome Analysis
por: Gotoh, Masahiro, et al.
Publicado: (2014)

Comprehensive analysis of immune implication and prognostic value of DHX33 in sarcoma
por: Zhang, Xinan, et al.
Publicado: (2023)

COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA
Publicado: (2013)

The Transcription Factor TCF1 in T Cell Differentiation and Aging
por: Kim, Chulwoo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1mqjcp0nomt5j48tbfbijn622r